Scholar Rock Holding buy Wedbush
Summary
This prediction is currently active. The BUY prediction by Wedbush for Scholar Rock Holding is performing very badly with a performance of -37.78%. This prediction currently runs until 07.05.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Scholar Rock Holding | -0.592% | -0.592% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by Wedbush for this prediction
In the thread Scholar Rock Holding diskutieren
Stopped prediction by Wedbush for Scholar Rock Holding
Scholar Rock Holding
31.10.23
31.10.24
02.09.24
Scholar Rock Holding
10.08.23
10.08.24
11.08.24